Wuhan Dazhong Dental Medical Co., Ltd. (HKG:2651)
Hong Kong · Delayed Price · Currency is HKD 9.60
+0.51 (5.61%)
At close: Feb 13, 2026
HKG:2651 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 |
| 388.33 | 407.08 | 441.84 | 409.44 | 81.18 | 58.25 | |
Revenue Growth (YoY) | -5.16% | -7.87% | 7.91% | 404.37% | 39.35% | 67.48% |
Cost of Revenue | 240.57 | 254.74 | 273.62 | 260.97 | 38.03 | 26.2 |
Gross Profit | 147.76 | 152.34 | 168.23 | 148.47 | 43.15 | 32.05 |
Selling, General & Admin | 70.95 | 75.35 | 77.24 | 75.7 | 29.01 | 23.07 |
Research & Development | 7.26 | 6.67 | 6.82 | 6.62 | - | - |
Other Operating Expenses | - | - | - | - | 0.2 | 0.02 |
Operating Expenses | 78.21 | 82.02 | 84.06 | 82.32 | 29.21 | 23.08 |
Operating Income | 69.55 | 70.32 | 84.17 | 66.16 | 13.94 | 8.97 |
Interest Expense | -5 | -5.33 | -5.51 | -6.68 | - | - |
Interest & Investment Income | 2.45 | 2.45 | 3.56 | 3.07 | - | - |
Other Non Operating Income (Expenses) | -0.97 | 1.05 | -0.75 | 0.14 | -0.21 | 0.95 |
EBT Excluding Unusual Items | 66.04 | 68.49 | 81.47 | 62.69 | 13.73 | 9.91 |
Gain (Loss) on Sale of Investments | - | - | -0.12 | - | - | - |
Gain (Loss) on Sale of Assets | -0.51 | -0.51 | -0.52 | 1.4 | - | - |
Asset Writedown | - | - | - | - | -0.03 | 0 |
Other Unusual Items | 3.04 | 2.84 | -1.92 | -0.58 | - | - |
Pretax Income | 68.57 | 70.82 | 78.91 | 63.51 | 13.7 | 9.92 |
Income Tax Expense | 6.71 | 8.32 | 11.87 | 7.06 | 3.43 | 1.99 |
Earnings From Continuing Operations | 61.86 | 62.5 | 67.04 | 56.45 | 10.28 | 7.93 |
Minority Interest in Earnings | -24.48 | -20.58 | -16.97 | -13.11 | - | - |
Net Income | 37.37 | 41.92 | 50.07 | 43.34 | 10.28 | 7.93 |
Preferred Dividends & Other Adjustments | 5.28 | 5.38 | 6.14 | 5.32 | - | - |
Net Income to Common | 32.1 | 36.53 | 43.93 | 38.03 | 10.28 | 7.93 |
Net Income Growth | -13.77% | -16.28% | 15.52% | 321.79% | 29.61% | 241.24% |
Shares Outstanding (Basic) | 35 | 39 | 41 | 41 | 29 | 20 |
Shares Outstanding (Diluted) | 35 | 39 | 41 | 41 | 29 | 20 |
Shares Change (YoY) | -15.27% | -5.09% | - | 44.15% | 44.01% | 138.86% |
EPS (Basic) | 0.92 | 0.94 | 1.07 | 0.92 | 0.36 | 0.40 |
EPS (Diluted) | 0.92 | 0.94 | 1.07 | 0.92 | 0.36 | 0.40 |
EPS Growth | -0.38% | -12.37% | 15.52% | 156.72% | -10.00% | 42.86% |
Free Cash Flow | 68.69 | 77.22 | 130.48 | 105.97 | -6.52 | 2.27 |
Free Cash Flow Per Share | 1.97 | 1.98 | 3.17 | 2.58 | -0.23 | 0.11 |
Gross Margin | 38.05% | 37.42% | 38.07% | 36.26% | 53.15% | 55.02% |
Operating Margin | 17.91% | 17.27% | 19.05% | 16.16% | 17.17% | 15.39% |
Profit Margin | 8.27% | 8.97% | 9.94% | 9.29% | 12.66% | 13.61% |
Free Cash Flow Margin | 17.69% | 18.97% | 29.53% | 25.88% | -8.04% | 3.90% |
EBITDA | 92.15 | 91.38 | 107.27 | 90.2 | 17.65 | 11.71 |
EBITDA Margin | 23.73% | 22.45% | 24.28% | 22.03% | 21.74% | 20.10% |
D&A For EBITDA | 22.59 | 21.06 | 23.1 | 24.05 | 3.71 | 2.74 |
EBIT | 69.55 | 70.32 | 84.17 | 66.16 | 13.94 | 8.97 |
EBIT Margin | 17.91% | 17.27% | 19.05% | 16.16% | 17.17% | 15.39% |
Effective Tax Rate | 9.79% | 11.74% | 15.04% | 11.11% | 25.01% | 20.07% |
Revenue as Reported | - | - | - | - | 81.18 | 58.25 |
Advertising Expenses | - | 32.4 | 37.15 | 34.45 | - | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.